HEIQ.L

HeiQ Plc
HeiQ PLC - Director/PDMR Shareholding
18th November 2024, 07:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 5192M
HeiQ PLC
18 November 2024
 

18 November 2024

 

HeiQ Plc

("HeiQ" or "the Company")

Director / PDMR Dealing

HeiQ Plc (LSE: HEIQ), a leading company in materials innovation and hygiene technologies, has been notified that on 15 December 2024, Xaver Hangartner, Chief Finance Officer, and Karen Brade, Non-Executive Director, purchased shares in the company, as follows:

Name

Number of Shares

Price

Xaver Hangartner

139,694

100,000

£0.040

£0.041

Karen Brade

40,263

£0,0471

 

Following the purchases, Mr. Hangartner holds an interest in 806,808 Ordinary Shares and Ms. Brade holds an interest in 80,526 Ordinary Shares, representing approximately 0.48% and 0.05% per cent. of the Company's issued ordinary share capital respectively.

This announcement, including the notification below, is made in accordance with the requirements of the UK Market Abuse Regulation.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

(i)           Mr. Xaver Hangartner

(ii)          Ms. Karen Brade

2

 

Reason for the notification

 

a)

 

Position/status

 

 

(i)           Chief Finance Officer

(ii)          Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

HeiQ plc

b)

 

LEI

 

 

213800IGT65IMJDO4S03

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of GBP 0.05 each

 

 

GB00BN2CJ299

 

b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Name

Price(s)

 

Volume(s)

(i)  Mr Xaver Hangartner

0.040 and 0.041

139,694 and 100,000

(ii) Ms Karen Brade

0.0471

 

40,263

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

 15 November 2024

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market

 

 For further information, please contact:

HeiQ Plc

Carlo Centonze (CEO)

+41 56 250 68 50

Cenkos Securities plc (Joint Broker)

Stephen Keys / Callum Davidson

+44 (0) 207 397 8900

SEC Newgate (Media Enquiries)

Elisabeth Cowell / Tom Carnegie / Molly Gretton

+44 (0) 20 3757 6882

HeiQ@secnewgate.co.uk

 


 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFLTLLLDLIS]]>
TwitterFacebookLinkedIn